Visitors
CN 74 BH 24 IT 22 US 8 RU 7 BR 7 SG 6 LU 5 PH 5 DE 4 CH 4 GB 2 JP 2 BE 2 QA 1 IL 1 IN 1 PK 1 SA 1 NL 1

国际尿石症联盟

Home > Faculty > National Faculty

    Jinchun Xing

    • CountryChina
    1. Detailed Informations

    Education

    1982.9~1987.7     B.A. Tongji Medical School, Huazhong University of

                     Science and Technology,

    1987.9~1990.7     M.A.(Urology), Tongji Medical School, Huazhong University

    of Science and Technology,

    2003.03~2003.09   Visiting professor, Urology and Minimally Invasive Surgery Center of Duke University Medical Center

    2007.09~2011.07   M. D .(Urology) Tongji Medical University

    2007.10           Visiting professor,  Department of Urology,   Los Angeles (UCLA) ,  California

    2008.06           Visiting professor, Cancer Center of Harvard University

    Experience

    1990.9~1994.2      Department of Urology, First Affiliated Hospital of Xiamen University, assistant urologist

    1994.2~1996.6      Department of Urology, First Affiliated Hospital of Xiamen University, attending urologist

    1996.6~1999.8      Department of Urology, Nyangabgwe Hospital, Republic of Botswana (in the southern Africa), attending urologist (expert of medical aid)

    1999.8~2002.7      Department of urology, First Affiliated Hospital of Xiamen University, deputy director

    2002.7~ 2006.1     associate professor of Xiamen University

    2006.1~present      professor of Xiamen University

     

    Present Positions

    ²     Dean of Xiamen Urology Center

    ²     Chairman of Department of Urology, First Affiliated Hospital of Xiamen University

    ²     Membership of first batch of medical academic and technological leaders of Xiamen City

    ²     Member of  experts committee for diplomate admittance of National Health and Family Planning Commission of P.R.China

    ²     Member of Chinese Medical Association medical appraisal expert panel

    ²     Vice director of East-China Urinary Stones Prevent and Control Base of CUA

    ²     Director of Xiamen Medical quality control center for Urology

    Position in Medical Association:

    ²     Vice Chairman of Fujian Urological Association, Branch of Fujian Medical Association;

    ²     Chairman of Xiamen Urological Association, Branch of Xiamen Medical Association;

    ²     Committee Member of Chinese Urological Association(9th,10th);

    ²     Membership of  Société Internationale d'Urologie (SIU);

    ²     Membership of the European Association of Urology;

    ²     Membership of American Urological Association;

    ²      Vice-President of Chinese Urolithiasis Consortium (CUC);

    ²     Committee Member of IAU;

    ²     Committee member of Chinese Bladder Cancer Consortium (CBCC(1st)

    ²      Committee member of Chinese Kidney Cancer Consortium (1st)

    ²       

    Additional Positions

    ²     Editorial board member of Chinese Journal of Urology (8th )

    ²     Standing editorial board member of China Medical Engineering;

    ²     Editorial board member of China Journal of Endoscopy;

    ²     Editorial board member of China Journal of Modern Medicine;

    ²     Editorial board member of Journal of Contemporary Urologic and Reproductive Oncology;

    ²     Editorial board member of Journal of Modern Urology (4th);

    ²     Editorial board member of Journal of Minimally Invasive Urology 1st);

    ²     Editorial board member of Xiamen Journal of Medicine

    Publications (selected)

    1.       Urinary Metabolic Profiling Affords Noninvasive Diagnosis for Kidney, Bladder and Adrenal Cancers. CLINICAL CANCER RESEARCH.2009

    2.       Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? Aserum metabonomic study of kidney cancer.Analyst.2010,135: 2970-2978

    3.       Preparation and analytical application of mimetic enzyme hemin-loading magnetic silica nanotubes.Journal of Nanoscience and Nanotechnology. 2010105783-5789. 2009

    4.       A Comparative study of elution gradients in UPLC-TOF-MS-Based metabonomics research. Chromatographia.2010,7:807-813.

    5.       Multiplex immunodetection of tumor markers with a suspension array built upon core-shell structured functional fluorescence-encoded microspheres.Analytica Chimica Acta2010,665:63-68. 2009I

    6.       Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice. Transplant immunololgy. 2010. 24(2010):57-63.

    7.       The major histocompatibility complex(MHC) of the secondary transplant tissue donor influences the cross-reactivity of alloreactive memory cells. Scandinavian Journal of Immunology. 20107,190-197.

    8.       Bipola plasmakinetic transurethral resection of the prostate vs.transurethral enucleation and resection of the prostate:pre-and postoperative comparisons of parameters used in assessing benign prostatic enlargement. Singapore Med J.2011;52(10):747-751.

    9.       LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. Journal of proteome research,2011,10,1396-1405.2009

    10.    Bipola plasmakinetic transurethral resection of the prostate vs.transurethral enucleation and resection of the prostate:pre-and postoperative comparisons of parameters used in assessing benign prostatic enlargement. Singapore Med J.2011;52(10):747-751.

    11.    Urinary Metabolic Profiling Affords Noninvasive Diagnosis for Kidney, Bladder and Adrenal Cancers. CLINICAL CANCER RESEARCH.2009

    12.    LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. Journal of proteome research,2011,10,1396-1405.2009

    13.    Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice. Transplant immunology. 2010.24(2010): 57-63

    14.    Association of polymorphisms in angiotensin II receptor genes with aldosterone-producing adenoma. J Huazhong Univ Sci Technol [Med Sci], 2011, 31: 301-305.

    15.    Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance. Journal of BUON.2013.18(1):211-219


    Powered by MetInfo 5.3.17 ©2008-2018